Product Code: TMRGL800
Healthcare Contract Research Outsourcing Market - Scope of Report
TMR's report on the global healthcare contract research outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global healthcare contract research outsourcing market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global healthcare contract research outsourcing market from 2021 to 2028.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the healthcare contract research outsourcing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global healthcare contract research outsourcing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global healthcare contract research outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global healthcare contract research outsourcing market.
The report delves into the competitive landscape of the global healthcare contract research outsourcing market. Key players operating in the global healthcare contract research outsourcing market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global healthcare contract research outsourcing market profiled in this report.
Key Questions Answered in Healthcare Contract Research Outsourcing Market Report
What will be the sales/revenue generated by healthcare contract research outsourcing across all the geographies during the forecast period?
What are the key trends in the healthcare contract research outsourcing market?
What are the major drivers, restraints, and opportunities in the market?
Which region is set to grow at the highest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2028 and which services segment will grow at the highest CAGR during the forecast period?
Healthcare Contract Research Outsourcing Market - Research Objectives and Research Approach
The comprehensive report on the global healthcare contract research outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global healthcare contract research outsourcing market in terms of service, therapeutic area, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global healthcare contract research outsourcing market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Healthcare Contract Research Outsourcing Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Service Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017-2028
- 4.4.1. Market Revenue Projections (US$ Mn)
- 4.4.2. Market Volume/Unit Shipments Projections
- 4.5. Porter's Five Force Analysis
5. Key Insights
- 5.1. Key Mergers & Acquisitions
- 5.2. Regulatory Scenario by Region/globally
- 5.3. COVID-19 Impact Analysis
6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value & Volume Forecast, by Service, 2017-2028
- 6.3.1. Clinical Trial Services
- 6.3.2. Regulatory Services
- 6.3.3. Clinical Data Management & Biometrics
- 6.3.4. Medical Writing
- 6.3.5. Pharmacovigilance
- 6.3.6. Site Management Protocol
- 6.3.7. Others
- 6.4. Market Attractiveness Analysis, by Service
7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 7.3.1. Pharmaceutical Companies
- 7.3.2. Biotechnology Companies
- 7.3.3. Medical Devices
- 7.3.4. Academic Institutes & Government Organizations
- 7.4. Market Attractiveness Analysis, by End-user
8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 8.3.1. Oncology/Hematology
- 8.3.2. CNS
- 8.3.3. CV/Metabolic
- 8.3.4. Respiratory
- 8.3.5. Infectious Diseases
- 8.3.6. Immunology
- 8.3.7. Rare Diseases
- 8.3.8. Medical Devices
- 8.3.9. Others
- 8.4. Market Attractiveness Analysis, by Therapeutic Area
9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value & Volume Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value & Volume Forecast, by Service, 2017-2028
- 10.2.1. Clinical Trial Services
- 10.2.2. Regulatory Services
- 10.2.3. Clinical Data Management & Biometrics
- 10.2.4. Medical Writing
- 10.2.5. Pharmacovigilance
- 10.2.6. Site Management Protocol
- 10.2.7. Others
- 10.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 10.3.1. Pharmaceutical Companies
- 10.3.2. Biotechnology Companies
- 10.3.3. Medical Devices
- 10.3.4. Academic Institutes & Government Organizations
- 10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 10.4.1. Oncology/Hematology
- 10.4.2. CNS
- 10.4.3. CV/Metabolic
- 10.4.4. Respiratory
- 10.4.5. Infectious Diseases
- 10.4.6. Immunology
- 10.4.7. Rare Diseases
- 10.4.8. Medical Devices
- 10.4.9. Others
- 10.5. Market Value & Volume Forecast, by Country, 2017-2028
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Service
- 10.6.2. By End-user
- 10.6.3. By Therapeutic Area
- 10.6.4. By Country
11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value & Volume Forecast, by Service, 2017-2028
- 11.2.1. Clinical Trial Services
- 11.2.2. Regulatory Services
- 11.2.3. Clinical Data Management & Biometrics
- 11.2.4. Medical Writing
- 11.2.5. Pharmacovigilance
- 11.2.6. Site Management Protocol
- 11.2.7. Others
- 11.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 11.3.1. Pharmaceutical Companies
- 11.3.2. Biotechnology Companies
- 11.3.3. Medical Devices
- 11.3.4. Academic Institutes & Government Organizations
- 11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 11.4.1. Oncology/Hematology
- 11.4.2. CNS
- 11.4.3. CV/Metabolic
- 11.4.4. Respiratory
- 11.4.5. Infectious Diseases
- 11.4.6. Immunology
- 11.4.7. Rare Diseases
- 11.4.8. Medical Devices
- 11.4.9. Others
- 11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Service
- 11.6.2. By End-user
- 11.6.3. By Therapeutic Area
- 11.6.4. By Country/Sub-region
12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value & Volume Forecast, by Service, 2017-2028
- 12.2.1. Clinical Trial Services
- 12.2.2. Regulatory Services
- 12.2.3. Clinical Data Management & Biometrics
- 12.2.4. Medical Writing
- 12.2.5. Pharmacovigilance
- 12.2.6. Site Management Protocol
- 12.2.7. Others
- 12.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 12.3.1. Pharmaceutical Companies
- 12.3.2. Biotechnology Companies
- 12.3.3. Medical Devices
- 12.3.4. Academic Institutes & Government Organizations
- 12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 12.4.1. Oncology/Hematology
- 12.4.2. CNS
- 12.4.3. CV/Metabolic
- 12.4.4. Respiratory
- 12.4.5. Infectious Diseases
- 12.4.6. Immunology
- 12.4.7. Rare Diseases
- 12.4.8. Medical Devices
- 12.4.9. Others
- 12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Service
- 12.6.2. By End-user
- 12.6.3. By Therapeutic Area
- 12.6.4. By Country/Sub-region
13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value & Volume Forecast, by Service, 2017-2028
- 13.2.1. Clinical Trial Services
- 13.2.2. Regulatory Services
- 13.2.3. Clinical Data Management & Biometrics
- 13.2.4. Medical Writing
- 13.2.5. Pharmacovigilance
- 13.2.6. Site Management Protocol
- 13.2.7. Others
- 13.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 13.3.1. Pharmaceutical Companies
- 13.3.2. Biotechnology Companies
- 13.3.3. Medical Devices
- 13.3.4. Academic Institutes & Government Organizations
- 13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 13.4.1. Oncology/Hematology
- 13.4.2. CNS
- 13.4.3. CV/Metabolic
- 13.4.4. Respiratory
- 13.4.5. Infectious Diseases
- 13.4.6. Immunology
- 13.4.7. Rare Diseases
- 13.4.8. Medical Devices
- 13.4.9. Others
- 13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Service
- 13.6.2. By End-user
- 13.6.3. By Therapeutic Area
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value & Volume Forecast, by Service, 2017-2028
- 14.2.1. Clinical Trial Services
- 14.2.2. Regulatory Services
- 14.2.3. Clinical Data Management & Biometrics
- 14.2.4. Medical Writing
- 14.2.5. Pharmacovigilance
- 14.2.6. Site Management Protocol
- 14.2.7. Others
- 14.3. Market Value & Volume Forecast, by End-user, 2017-2028
- 14.3.1. Pharmaceutical Companies
- 14.3.2. Biotechnology Companies
- 14.3.3. Medical Devices
- 14.3.4. Academic Institutes & Government Organizations
- 14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017-2028
- 14.4.1. Oncology/Hematology
- 14.4.2. CNS
- 14.4.3. CV/Metabolic
- 14.4.4. Respiratory
- 14.4.5. Infectious Diseases
- 14.4.6. Immunology
- 14.4.7. Rare Diseases
- 14.4.8. Medical Devices
- 14.4.9. Others
- 14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2028
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Service
- 14.6.2. By End-user
- 14.6.3. By Therapeutic Area
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2020
- 15.3. Company Profiles
- 15.3.1. Syneos Health
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. PAREXEL International
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. ICON plc
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. PRA Health Sciences, Inc.
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Charles River
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Laboratory Corporation of America Holdings (Covance)
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. IQVIA
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Medpace
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Pharmaceutical Product Development, LLC.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview